Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

RemedyRepack Inc. recalls Duloxetine Delayed-Release Capsules

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.
Products
  • Duloxetine Delayed-Release Capsules
Where it was sold

Nationwide in the US

Nationwide

Units affected
a) 1,564 cards, b) 799 bottles
About this recall
Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Rising Pharma, Inc., Allendale, NJ, Repackaged by: RemedyRepack Inc., Indiana, PA